awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37338133-401D13B8-9388-46EF-B997-563A88F89C4F
Q37338133-401D13B8-9388-46EF-B997-563A88F89C4F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37338133-401D13B8-9388-46EF-B997-563A88F89C4F
Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.
P2860
Q37338133-401D13B8-9388-46EF-B997-563A88F89C4F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37338133-401D13B8-9388-46EF-B997-563A88F89C4F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
475a2a9ac44bdae7ed3549200486c3c390ef1c22
P2860
Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study.